Watson David O. 4
4 · Apellis Pharmaceuticals, Inc. · Filed Sep 12, 2025
Insider Transaction Report
Form 4
Watson David O.
General Counsel
Transactions
- Sale
Common Stock
2025-09-10$26.17/sh−20,000$523,400→ 50,136 total(indirect: By Trust)
Holdings
- 123,730
Common Stock
- 10,000(indirect: By Children)
Common Stock
Footnotes (3)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.15 to $26.20, inclusive. The reporting person hereby undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F2]The securities are held by The David O. Watson Irrevocable Trust of 2023. William Zorn is the trustee of The David O. Watson Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The David O. Watson Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
- [F3]This represents a custodial account held by the reporting person for the sole benefit of his minor children.